TrialBMC complementary and alternative medicine2015

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.

Chote Luangchosiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.